Abstract 4476: Targeted delivery of curcumin to improve therapeutic outcome in breast cancer
作者
Rajesh Singh,James W. Lillard
出处
期刊:Cancer Research [American Association for Cancer Research] 日期:2014-10-01卷期号:74 (19_Supplement): 4476-4476被引量:2
标识
DOI:10.1158/1538-7445.am2014-4476
摘要
Abstract Conventional chemotherapeutics offered to treat breast cancer (BrCa) are not selectively targeted. Due to this fact, they are toxic to the normal cells. It is imperative to identify new anti-cancer agents and/or methods to selectively target BrCa cells without affecting normal cells. In this regard, Curcumin, a plant polyphenol, has shown very promising results. Despite the proven anti-tumor effects of curcumin, clinical use of this compound is restricted due to its poor bioavailability. To surmount these problems, we developed nanoparticles, loaded with curcumin, using a planetary-balled milling (PBM) technique with particles tagged with folate for selective targeting to BrCa cells, which express high affinity folate receptors. Multispectral imaging, using an Amnis ImageStream system, was used to measure the response of curcumin-loaded PBM nanoparticles, and free curcumin on various BrCa cell lines. Curcumin-loaded folic acid-coated PBM nanoparticles selectively targeted and were taken-up by BrCa cells and induced apoptosis. Furthermore, our results indicate that targeted delivery of curcumin using PBM nanoparticles was 60 % more effective in killing BrCa cells at concentrations lower than the IC50 of free curcumin. Citation Format: Rajesh Singh, James W. Lillard. Targeted delivery of curcumin to improve therapeutic outcome in breast cancer. [abstract]. In: Proceedings of the 105th Annual Meeting of the American Association for Cancer Research; 2014 Apr 5-9; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2014;74(19 Suppl):Abstract nr 4476. doi:10.1158/1538-7445.AM2014-4476